Effects of Qigong Therapy on the Anaerobic Threshold in Patients with Stable Coronary Artery Disease: A Randomized Controlled Trial.

Autor: Zhao F; College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China., Liang C; Institute of Sports Medicine, General Administration of Sport of China, Beijing 100061, China., John Zaslawski C; University of Technology, Sydney 2007, Australia., Cao Z; College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China.
Jazyk: angličtina
Zdroj: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Sep 14; Vol. 2022, pp. 5690569. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022).
DOI: 10.1155/2022/5690569
Abstrakt: Objective: This study aims to identify whether Qigong (QG) rehabilitation therapy can significantly improve the cardiac function of patients with stable coronary artery disease (SCAD) compared with routine therapy. Thus, a randomized controlled trial was conducted to evaluate the curative effects of a three-month QG rehabilitation therapy on cardiac rehabilitation. Patients and Methods. In this trial, a total of 68 patients with SCAD were randomly divided into the QG group (34 patients) and the control (CON) group (34 patients). Patients in the CON group received routine cardiologic medication without any special intervention. Based on the treatment in the CON group, patients in the QG group were provided additionally with a 12-week traditional Chinese medicine (TCM) cardiac rehabilitation QG exercise training program. The outcomes of these patients were assessed at baseline and after 12 weeks of intervention through the treadmill (anaerobic threshold (AT)) test.
Results: After 12 weeks of intervention, the AT, volume of oxygen (VO2), oxygen uptake/kilogram (VO2/kg), metabolic equivalents (METS), and oxygen pulse (VO2/HR) of patients in the QG group were significantly higher than those of patients in the CON group ( P < 0.05).
Conclusion: QG therapy can achieve certain curative effects and safety for patients with SCAD. This trial is registered with Clinicaltrials . gov identifier (ChiCTR1800015823).
Competing Interests: The authors declare that there are no conflicts of interest.
(Copyright © 2022 Fengrun Zhao et al.)
Databáze: MEDLINE
Externí odkaz: